Cargando…
Current state of knowledge of hepatic encephalopathy (part III): non-absorbable disaccharides
Nonabsorbable disaccharides have been the mainstay of treatment for hepatic encephalopathy since introduced into clinical practice in 1966. Their beneficial effects reflect their ability to reduce the intestinal production/absorption of ammonia. A recent Cochrane review confirmed the efficacy and sa...
Autor principal: | Morgan, Marsha Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145904/ https://www.ncbi.nlm.nih.gov/pubmed/27638474 http://dx.doi.org/10.1007/s11011-016-9910-2 |
Ejemplares similares
-
Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis
por: Wu, Dong, et al.
Publicado: (2013) -
Is rifaximin better than nonabsorbable disaccharides in hepatic encephalopathy?: A meta-analysis
por: Cheng, Junxiong, et al.
Publicado: (2021) -
What Improves Minimal Hepatic Encephalopathy: Probiotic Yogurt, Protein Restriction or Nonabsorbable Disaccharides?
por: Alfawaz, Hanan A., et al.
Publicado: (2012) -
Terahertz spectral properties of glucose and two disaccharides in solid and liquid states
por: Huang, Haiyun, et al.
Publicado: (2022) -
Synthesis and Reactivity of
4′-Deoxypentenosyl
Disaccharides
por: Padungros, Panuwat, et al.
Publicado: (2014)